Related Experiment Video
Updated: Jul 13, 2026
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Potential therapeutic target genes for systemic lupus erythematosus: a bioinformatics analysis
Yun Yu1, Liang Liu1, Long-Long Hu1
1Department of Cardiovascular Medicine, Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Abstract:
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease involving multiple organs. However, the underlying etiology and mechanisms remain unclear. This study was performed to identify potential therapeutic targets for SLE using bioinformatics methods. First, 584 differentially expressed genes were identified based on the GSE61635 dataset. Tissue-specific analyses, enrichment analyses, and Protein-Protein interaction network were successively conducted. Furthermore, ELISA was performed to confirm the expression levels of key genes in the control and SLE blood samples. The findings revealed that tissue-specific expression of markers of the hematological system (25.5%, 28/110) varied significantly. CCL2, MMP9, and RSAD2 expression was markedly increased in the SLE samples compared with controls. In conclusion, the identified key genes (CCL2, MMP9, and RSAD2) may act as possible therapeutic targets for the treatment of SLE.
Insights
Researchers identified key genes CCL2, MMP9, and RSAD2 as potential therapeutic targets for systemic lupus erythematosus (SLE), a chronic autoimmune disease. These findings offer new avenues for SLE treatment development.
Area of Science:
- Immunology
- Genomics
- Bioinformatics
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disorder affecting multiple organs.
- The precise causes and disease mechanisms of SLE are not fully understood.
- Identifying novel therapeutic targets is crucial for effective SLE management.
Purpose of the Study:
- To identify potential therapeutic targets for SLE using bioinformatics approaches.
- To analyze gene expression patterns in SLE patients.
- To validate key gene candidates through experimental methods.
Main Methods:
- Differential gene expression analysis using the GSE61635 dataset.
- Bioinformatic analyses including tissue-specific expression, enrichment analysis, and protein-protein interaction networks.
- Enzyme-linked immunosorbent assay (ELISA) to confirm gene expression in patient blood samples.
Main Results:
- Identified 584 differentially expressed genes in SLE.
- Significant variations in tissue-specific expression of hematological system markers were observed.
- Expression of CCL2, MMP9, and RSAD2 was significantly elevated in SLE patients compared to controls.
Conclusions:
- CCL2, MMP9, and RSAD2 are identified as potential key therapeutic targets for SLE.
- These genes may play a significant role in SLE pathogenesis.
- Further research into these targets could lead to novel SLE treatments.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
01:29Pharmacogenomics: Identification of New Drug Targets